Potential utilization of Artemiafranciscana eggs as food for Coleomegillamaculata

E. Riddick,Zhixin Wu,M. Rojas

DOI: https://doi.org/10.1007/s10526-014-9597-4

2014-07-04

Abstract:

What problem does this paper attempt to address?

Aspects of energetic substrate metabolism of in vitro and in vivo bovine embryos

D. K. de Souza,L. Salles,A. R. E. Rosa e Silva

DOI: https://doi.org/10.1590/1414-431X20143744

2015-01-23

Abstract:Although the metabolism of early bovine embryos has not been fully elucidated, several publications have addressed this important issue to improve culture conditions for cattle reproductive biotechnologies, with the ultimate goal of producing in vitro embryos similar in quality to those developing in vivo. Here, we review general aspects of bovine embryo metabolism in vitro and in vivo, and discuss the use of metabolic analysis of embryos produced in vitro to assess viability and predict a viable pregnancy after transference to the female tract.
Effect of 17Β-Estradiol on the Migration Ability of Human Osteosarcoma U2OS Cells

Zhengming Yang,Minfei Yang,Huimin Tao,Bin Liu,Libin Jin

DOI: https://doi.org/10.21037/tcr.2018.09.05

2018-01-01

Translational Cancer Research

Abstract:Background: To investigate the effect of 17β-estradiol on the migration ability of human osteosarcoma U2OS cells. Methods: Six concentrations of 17β-estradiol were tested in the U2OS cells, and the minimum concentration that could significantly affect the cells’ migration ability was determined by CCK-8 growth assay and cell scratch test. Furthermore, five concentrations of 17β-estradiol were used to detect the cells’ proliferation and migration ability by CCK-8 growth test, cell scratch test, transwell invasion assay, and crystal violet staining. Results: Cell viability decreased with increasing concentrations of 17β-estradiol at 24 h, and also exhibited significant changes at the treatment concentration of 1/25×10 −10 M in the CCK-8 test. The cell scratch test and crystal violet staining showed that 17β-estradiol (10 −10 M) can significantly inhibit the migration ability of U2OS cells; the transwell invasion assay showed that with increasing concentrations of 17β-estradiol, the number of invading cells began to decrease significantly at the concentration of 1/25×10 −10 M. Conclusions: 17β-estradiol can inhibit the migration of U2OS cells, starting at a concentration of 10 −10 , and in a concentration-dependent manner.
Food-based nutrition education and hygiene can improve the growth of stunted children.

John H. Himes,David R. Jacobs

DOI: https://doi.org/10.1079/BJN20041127

2004-05-01

British Journal Of Nutrition

Abstract:
The Impact of Stapes Surgery on Osteogenesis Imperfecta: a Retrospective Comparison of Operative Outcomes with Those for Patients with Otosclerosis

Xiaoyan Ma,Fangyuan Wang,Weidong Shen,Shiming Yang

DOI: https://doi.org/10.1080/00016489.2020.1786161

IF: 1.698

2020-01-01

Acta Oto-Laryngologica

Abstract:Background While stapes surgery has long been employed as a means of improving hearing in patients with otosclerosis, it remains controversial as to whether such surgical intervention is of value in patients with osteogenesis imperfecta (OI). Aims This study was therefore designed to determine whether stapes surgery could still be reliably performed in OI patients as it is in otosclerosis patients. Materials and methods Seventeen OI patients and 18 matched otosclerosis patients were included. In both of these groups, 22 ears underwent primary stapes surgery. Audiometric follow-up data for patients in these two treatment groups were available for between 2 weeks and 25 years post-surgery. Results We detected significant improvements in both the short- and long-term mean air conduction threshold and reduced air-bone gap (ABG) in both treatment groups as measured via postoperative follow-up audiometry. There was no difference between the OI and otosclerosis patient groups with respect to short- and long-term postoperative audiometric. Conclusions and significance:The majority of patients with both OI and otosclerosis that underwent stapes surgery achieved beneficial gains in hearing function. We did not observe any differences in short- or long-term post-operative hearing gains or ABG reductions between the two groups.
SUN-LB003 the Steroid Sulfatase Dictates the Hormone Replacement Therapy Efficacy of the Conjugated Equine Estrogen

Ye Feng,Yang Xie,Linhao Li,Meishu Xu,Hongbing Wang,Chaohui Yu,Wen Xie

DOI: https://doi.org/10.1210/js.2019-sun-lb003

2019-01-01

Journal of the Endocrine Society

Abstract:Abstract Conjugated equine estrogen (CEE) is widely used in hormone replacement therapy in postmenopausal women. Extracted from pregnant mare urine, CEE is composed of nearly a dozen estrogens existing in their inactively sulfated forms. The goal of this study is to determine whether the steroid sulfatase (STS), the enzyme responsible for steroid desulfation and re-activation, is the major contributor to the hormone replacement therapy effect of CEE. To study the role of STS in CEE’s effect, we performed estrogen responsive element (ERE) reporter gene assay, real-time PCR and UPLC/MS-MS to measure the STS dependent estrogenic activity of CEE in HepG2 cells and human primary hepatocytes (HPH). The effect of STS on the estrogenic activity of CEE was also valuated in vivo by using the STS transgenic mice. Our results showed that the activity of ERE reporter was induced by CEE in a STS-dependent manner, because the estrogenic activity of CEE was attenuated by genetic or pharmacological inhibition of STS. In HepG2 cells and HPH, the estrogenic activity of CEE was enhanced by inflammation via the induction of endogenous STS gene expression. The inflammatory responsive estrogenic activity of CEE in return can attenuate inflammation due to the anti-inflammatory activity of estrogens. In vivo, STS transgenic mice exhibited markedly increased sensitivity to CEE-induced estrogenic activity in the uterus. In conclusion, our results revealed an essential role of STS in mediating the hormone replacement activity of CEE. Cautions need to apply when CEE is used in patients of chronic inflammatory disease, because these patients may have heightened sensitivity to CEE due to the inflammatory induction of STS. Unless otherwise noted, all abstracts presented at ENDO are embargoed until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.
The Disease-Modifying Effect of Dehydroepiandrosterone in Different Stages of Experimentally Induced Osteoarthritis: a Histomorphometric Study

Kai Huang,Jia-peng Bao,Gavin James Jennings,Li-dong Wu

DOI: https://doi.org/10.1186/s12891-015-0595-1

IF: 2.562

2015-01-01

BMC Musculoskeletal Disorders

Abstract:Background: Osteoarthritis (OA) is likely to become an increasing burden in the coming decades. Various agents have been developed to slow the progression of OA, and are collectively known as 'disease-modifying drugs', however, there is still little reliable evidence that such agents will be successful. Dehydroepiandrosterone (DHEA), a sex hormone precursor, has been recently proven as protective agent against OA, but the exact mechanism is still unkown. In the current study, the effects of weekly intra-articular injections of DHEA in preventing the progression of existing cartilage degeneration in an OA rabbit model were evaluated. The aim of the current study is to demonstrate the feature of its disease-modifying efficacy during OA progression.Methods: Thirty male New Zealand white rabbits were used in this study. An anterior cruciate ligament transection (ACLT) model was used to create a progressive OA model in twenty rabbits. The animals were treated with DHEA or a placebo and were necropsied at 9 and 16 weeks. Ten rabbits receiving sham operations served as controls. The articular cartilage of the medial femoral condyle (MFC), lateral femoral condyle (LFC), medial tibial plateau (MTP) and lateral tibial plateau (LTP) was evaluated macroscopically and histologically.Results: In the joints of the sham-operated rabbits, few histological changes were detected on the articular surfaces of the femoral condyles and tibial plateaus. ACLT obviously induced erosive changes on the cartilage surfaces. Compared to the placebo group, the macroscopic and Mankin score analyses demonstrated that the DHEA treatment markedly reduced the cartilage lesions and delayed cartilage degeneration in the four regions of the knee at 9 weeks after operation (macroscopic score: MFC P = 0.013; LFC P = 0.048; MTP P = 0.045; LTP P = 0.02, Mankin score: MFC P = 0.012; LFC P = 0.034; MTP P = 0.016; LTP P = 0.002). At 16 weeks, DHEA demonstrated chondroprotective effects on the lateral compartment of the knee compared to the placebo group, whereas the cartilage degeneration at the medial compartment of the knee did not differ among the groups (macroscopic score: LFC P = 0.046; LTP = 0.034, Mankin score: LFC P = 0.005; LTP P = 0.002).Conclusion: The disease-modifying efficacy of DHEA aganist OA is time-specific and site-dependent. DHEA could be used as a disease-modifying strategy to limit the progression of OA, especially in the middle stage.
Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

Xiao-lin TANG,Huan-xin MENG,Li ZHANG,Jian-xia HOU,Jie HAN

DOI: https://doi.org/10.3321/j.issn:1671-167X.2007.01.014

2007-01-01

Abstract:Objective: To investigate the effect of 17-β estradiol (E_2)on the expression of receptor activator of nuclear factor κB ligand(RANKL) and osteoprotegerin(OPG) in human periodontal ligament cells( hPDLCs) during their osteogenic differentiation. Methods: hPDLCs of passage four were treated with 0.1% absolute ethyl alcohol (control), 10 -10 mol/L(physiological dose)or 10 -7 mol/L(high dose)E_2 in DMEM supplemented with 10% FBS, 10 mM β-glycerophosphate and 5 μg/ml ascorbic acid for 24 hours, 48 hours and 72 hours. Levels of RANKL and OPG mRNA were detected with real-time quantitative RT-PCR. Results: High dose E_2 induced a time-dependent decrease of RANKL mRNA and expression levels were 31.0%, 23.6% and 15.4% of the controls at 24 h, 48 h and 72 h respectively while expression levels with physiological dose E_2 were 28.4%, 87.3% and 22.6% of the controls respectively. On the other hand, E_2 increased OPG mRNA expression levels of hPDLCs which reached the maximum at 72 h with physiological dose E_2, 210.1% of the controls and with high dose E_2, 171.3% of the controls. Conclusion: These results suggest that estrogen may exert anti-resorptive effects on alveolar bone by regulating the expression of RANKL and OPG in hPDLCs during their osteogenic differentiation.
Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions

Hong-Mei Zhang,Yiqiang Zhang

DOI: https://doi.org/10.1111/jpi.12162

2014-09-01

Journal of Pineal Research

Abstract:Melatonin (N‐acetyl‐5‐methoxytryptamine), an indoleamine produced in many organs including the pineal gland, was initially characterized as a hormone primarily involved in circadian regulation of physiological and neuroendocrine function. Subsequent studies found that melatonin and its metabolic derivatives possess strong free radical scavenging properties. These metabolites are potent antioxidants against both ROS (reactive oxygen species) and RNS (reactive nitrogen species). The mechanisms by which melatonin and its metabolites protect against free radicals and oxidative stress include direct scavenging of radicals and radical products, induction of the expression of antioxidant enzymes, reduction of the activation of pro‐oxidant enzymes, and maintenance of mitochondrial homeostasis. In both in vitro and in vivo studies, melatonin has been shown to reduce oxidative damage to lipids, proteins and DNA under a very wide set of conditions where toxic derivatives of oxygen are known to be produced. Although the vast majority of studies proved the antioxidant capacity of melatonin and its derivatives, a few studies using cultured cells found that melatonin promoted the generation of ROS at pharmacological concentrations (μm to mm range) in several tumor and nontumor cells; thus, melatonin functioned as a conditional pro‐oxidant. Mechanistically, melatonin may stimulate ROS production through its interaction with calmodulin. Also, melatonin may interact with mitochondrial complex III or mitochondrial transition pore to promote ROS production. Whether melatonin functions as a pro‐oxidant under in vivo conditions is not well documented; thus, whether the reported in vitro pro‐oxidant actions come into play in live organisms remains to be established.
Effects of 17Β-Estradiol on Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and Adipocytic Trans-Differentiation of Osteoblasts

LI Xiang-hui,ZHANG Jin-chao,LIU Chang-zhen,SUI Sen-fang,YANG Meng-su

DOI: https://doi.org/10.3321/j.issn:1001-2494.2006.17.008

2006-01-01

Abstract:OBJECTIVE To study the effects of 17 β-estradiol on the osteogenic and adipogenic differentiation of primary mouse bone marrow stromal cells(MSCs)and the adipocytic trans-differentiation of primary mouse osteoblasts(OBs). METHODS 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide(MTT)was used to study the effects of 17 β-estradiol on the growth of MSCs and OBs, alkaline phosphatase(ALP)activity assay was used to study the effects of 17 β-estradiol on osteogenic differentiation of MSCs, and Oil Red O assay was used to study the effects of 17 β-estradiol on the adipogenic differentiation of MSCs and adipocytic trans-differentiation of OBs. RESULTS 17 β-estradiol promoted the proliferation of primary mouse bone marrow stromal cells and primary mouse osteoblasts at the concentrations of 1×10~ -8 , 1×10~ -7 , 5×10~ -7 , 1×10~ -6 , 5×10~ -6 and 1×10~ -5 mol·L~ -1 (P0.05). 17 β-estradiol promoted osteogenic differentiation and inhibited the adipogenic differentiation of MSCs at the concentrations of 5×10~ -7 , 1×10~ -6 , 5×10~ -6 and 1×10~ -5 mol·L~ -1 , but inhibited the osteogenic differentiation and promoted adipogenic differentiation of MSCs at the concentration of 1×10~ -7 mol·L~ -1 (P0.05). 17 β-estradiol inhibited the adipocytic transdifferentiation of OBs at the concentrations of 1×10~ -8 , 5×10~ -7 , 1×10~ -6 , 1×10~ -5 mol·L~ -1 (P0.05). CONCLUSION 17 β-estradiol can modulate the differentiation of marrow stromal cells to cause a lineage shift toward the osteoblast and away from the adipocyte and inhibit the adipocytic trans-differentiation of osteoblasts.
Interactive use of a computer in the preparation of structured programs

R. Snowdon

Abstract:
Effect of 17β-estradiol on the gene expression of estrogen receptors and estrogen related-receptor α in the periosteum-derived osteogenic cells

HUANG Man-ting,LIU Yong,LIN Shou-qing

DOI: https://doi.org/10.3760/j.issn:0253-2352.2006.09.011

2006-01-01

Abstract:Objective To study the gene expression of estrogen receptors(ER)and estrogen related-receptor α(ERRα)in the periosteum-derived osteogenic cells and its relationship with the regulation of estrogen.Methods The 6-week-old female Wistar rat calvaria periosteum-derived osteogenic cells were divided 10 groups and cultured in different medium for 7 days.One group severved as control group,and cultured in osteogenic inducing medium.The other 9 group severved as experimental group,and the culture medium contained 0.01,0.05,0.1,0.25,0.5,0.75,1,5,10 nmol/L 17β-estradiol(17β-E2).All RNA was extracted,and then using RT-PCR assay to determine the effects of 17β-E2 on the mRNA expression level of ER and ERRα.Results ERα expression was negative.ERβ expression level was relatively low.There was gradually increasing trend for the expression level of ERβ from 0 to 0.25 nmol/L 17β-E2 treatment.The ERβ expression level of 5 and 10 nmol/L groups was significantly lower than the other 17β-E2 treatment groups.ERRα expression was positive.The expression level of 17β-E2 treatment group was significantly higher than control group(P< 0.01).0.25 nmol/L group has the highest expression level,followed by 0.5 nmol/L group.Both of them have significantly higher expression level than the other 17β-E2 treatment groups.The expression level in 10 nmol/L group significantly lower than that in the other 17β-E2 treatment groups.Conclusion Estrogen may increase the ERRα expression level of periosteum-derived osteogenic cells.Low concentration of estrogen may increase the ERβ expression level.Maintaining serum 17β-E2 concentration at physiological level of the early and late follicular phase may obtain the optimal bone-protecting effect.
[7. Let's write a research paper soon after returning; introduction of the international journals related to radiological technology and members' real experiences].

R. Tanaka

DOI: https://doi.org/10.6009/JJRT.67.98

Abstract:
Estrogen's Stimulating Effect on ATDC5

B. Lu,J. Dai,D. Shi,Q. Jiang

DOI: https://doi.org/10.1016/j.joca.2012.02.223

IF: 7.507

2012-01-01

Osteoarthritis and Cartilage

Abstract:Purpose: The prevalence of knee osteoarthritis between Menopausal woman increase sharply. There are many studies indicate that the level of serum estrogen is associated with the morbidity of knee OA tightly. This study, using the cell culturing technology, was to observe what different results would come out from the MTT assay of the ATDC5 cell proliferation, whick had been cultured with different concentration E2. Methods: The 17-βestradiol we use was ordered from Sigma co. and the ATDC5 cell line was form the Riken cell bank. We culture the ATDC5 24 hours in the media with different concentration 17-βestradiol, then we test the OD value of the different cells in MTT assay to assume the proliferation of the ATDC5. Results: After culturing 24 hours in the media with different concentration 17-βestradiol, the proliferation of the ATDC5 in different concentration 17-βestradiol were different significantly, the higher of the concentration, the higher of the proliferation, as follows: beside the 10-11M against 0 M, the 10-10,10-9,10-8 and 10-7 M have significant difference in stimulating the proliferation of ATDC5 against 0 M. between the different concentration groups, only 10-8 M has significant difference against 10-11,10-10 M. Conclusions: First, 17-βestradiol has stimulation on the proliferation of ATDC5. Second, 10-8 M concentration of 17-βestradiol has the strongest stimulating effect than the other concentration of 17-βestradiol.
Effect of stapes demineralisation on the development of cochlear otosclerosis

Maciej Wiatr,Robert Bartoszewicz,Kazimierz Niemczyk,Agnieszka Wiatr

DOI: https://doi.org/10.14639/0392-100x-n2389

2024-02-01

Acta Otorhinolaryngologica Italica

Abstract:Objective: The involvement of the inner ear in otosclerosis may lead to the development of cochlear otosclerosis. The aim of this study was to analyse changes in the chemical composition and microstructure of the stapes in the course of otosclerosis compared to healthy stapes.Materials and methods: This analysis included 31 patients with otosclerosis and 9 patients without otosclerosis. Microanalytical and diffraction techniques were used to assess the elemental distribution and orientation topography of the stapes.Results: The concentration of Ca2+ in the study group was significantly lower in the area of the anterior crus of the stapes than in the posterior crus. A reduction in the Ca2+/P3+ ratio in the anterior crus was associated with deteriorated bone conduction and tinnitus. Degradation of the stapes microstructure in the area of otosclerotic lesions was observed with scanning electron microscopy.Conclusions: Bone remodelling is most significant at the closest location to typical otosclerotic lesions with hydroxyapatite porosity and scale-like bone formation according to scanning electron microscopy. There is a relationship between the disturbance of calcium metabolism and the development of clinical symptoms of cochlear otosclerosis.

otorhinolaryngology
Estrogens and Hyperglycemic Modulation of mRNAs Expressions Involved in Bone Metabolism: An Overshadowed Association?

Dalia Somjen,Sara Katzburg,Orli Sharon,Esther Knoll,Naftali Stern

DOI: https://doi.org/10.3109/03008207.2013.772596

2013-04-15

Connective Tissue Research

Abstract:Human bone cell line (SaOS2) express different mRNAs involved in bone biology and physiology such as estrogen receptor α (ERα), estrogen receptor β (ERβ), vitamin D receptor (VDR), 1α, 25 hydroxy vitamin D(3) hydroxylase (1OHase) as well as 12 and 15 lipoxygenases (12LO and 15LO). These mRNAs are modulated by estrogenic compounds. Since the skeletal protective effects of estrogens are not discernible in diabetic women, we tested whether the expression of the parameters measured here and their modulations by estrogens, in SaOS2 cells grown in growth medium containing high glucose (HG; 9.0 g/L; 44 mM) compared to normal glucose (NG; 4.5 g/L; 22 mM). High Glucose (HG) significantly increased DNA synthesis and creatine kinase (CK) specific activity in SaOS2 cells. Stimulations of DNA but not of CK by E(2), by 4, 4', 4''-[4-propyl-(1H)-pyrazol-1, 3, 5- triyl] tris-phenol (PPT, ERα specific agonist), or by 2, 3-bis (4-hydroxyphenyl)-propionitrile (DPN, ERβ specific agonist), were abolished by HG. HG itself upregulated the expression of mRNA of 12LO and 15LO and upregulated to much less extent of ERβ and VDR, but had no effect on the expression of mRNA of ERα and 1OHase. The different hormonal treatments modulated the expressions of 12LO and 15LO mRNAs which was reduced in HG, whereas the induction of their products 12HETE and 15HETE was only slightly affected by HG. The exact mechanism of HG effects on bone cell responses is yet to be investigated and its relationship to human bone physiology is not yet clear.

cell biology,orthopedics
Altered extracellular matrix and mechanotransduction gene expression in rat bone tissue following long-term estrogen deficiency

Syeda Masooma Naqvi,Laura M O'Sullivan,Hollie Allison,Vincent J Casey,Jessica Schiavi-Tritz,Laoise M McNamara

DOI: https://doi.org/10.1093/jbmrpl/ziae098

2024-07-24

JBMR Plus

Abstract:Osteoporosis is primarily associated with bone loss, but changes in bone tissue matrix composition and osteocyte mechanotransduction have also been identified. However, the molecular mechanisms underlying these changes and their relation to bone loss are not fully understood. The objectives of this study were to (1) conduct comprehensive temporal gene expression analyses on cortical bone tissue from ovariectomized rats, with a specific focus on genes known to govern matrix degradation, matrix production, and mechanotransduction, and (2) correlate these findings with bone mass, trabecular and cortical microarchitecture, and mineral and matrix composition. Microarray data revealed 35 differentially expressed genes in the cortical bone tissue of the ovariectomized cohort. We report that catabolic gene expression abates after the initial accelerated bone loss period, which occurs within the first 4 wk of estrogen deficiency. However, in long-term estrogen deficiency, we report increased expression of genes associated with extracellular matrix deposition (Spp1, COL1A1, COL1A2, OCN) and mechanotransduction (Cx43) compared with age-matched controls and short-term estrogen deficiency. These changes coincided with increased heterogeneity of mineral-to-matrix ratio and collagen maturity, to which extracellular matrix markers COL1A1 and COL1A2 were positively correlated. Interestingly, mineral heterogeneity and collagen maturity, exhibited a negative correlation with PHEX and IFT88, associated with mechanosensory cilia formation and Hedgehog (Hh) signaling. This study provides the first insight into the underlying mechanisms governing secondary mineralization and heterogeneity of matrix composition of bone tissue in long-term estrogen deficiency. We propose that altered mechanobiological responses in long-term estrogen deficiency may play a role in these changes.
Effects of estrogen treatment on the proliferation and differentiation of bone marrow stromal cells from normal rats and osteoporosis rats

ZHENG Biqiong,YAN Fuhua,LUO Kai

2007-01-01

Abstract:Objective To investigate the proliferation and differentiation of bone marrow stromal cells (BMSCs) from sham-operated rats and ovariectomized rats, and to evaluate the effects of 17β-estradiol (E_2) treatment on the proliferation and differentiation of cells in the two groups.Methods Three-month-old female rats were randomly divided into two groups: sham-operated rats (the Sham) and ovariectomized rats (the OVX). Six weeks later, we gained the serum and one tibial bone of each of two groups to make sure that the models of osteoporosis were established. After collecting the BMSCs from two groups, culturing them in vitro, and treating some with E_2, we evaluated the proliferation by MTT and the differentiation by comparing synthesized alkaline phosphatase (ALP). Results The primary cells from two groups were always cultured to form colonies. And the cells shared the characteristic with osteoblast as they synthesized ALP. They appeared like shuttles. In the third passage, we found that the proliferation of the cells from the Sham was slow all the way. Our research results showed the synthesized ALP by the cells from the Sham was obviously less than that synthesized by the ones from the OVX. Just a small change occurred when the cells from the Sham were treated with E_2. But in the other, the change was big. Conclusions The cells from two group showed the characteristic of osteoblast. In the third passage, not only the cells from the OVX showed much greater growth potential and compounded much more ALP, but also E_2 could promote the proliferation and differentiation of the cells from the OVX much more.
Effects of 17 beta-estradiol on osteogenic differentiation of rat primary cultured bone marrow mesenchymal stem cells

Han Na,Kou Yu-hui,Wang Tian-bing,Yin Xiao-feng,He Pei-ying,Zhang Pei-xun

DOI: https://doi.org/10.3969/j.issn.1673-8225.2012.10.003

2012-01-01

Abstract:BACKGROUND:The estrogen receptor exists in bone marrow mesenchymal stem cells and estrogen promotes bone formation by regulating the proliferation and differentiation of bone marrow mesenchymal stem cells.OBJECTIVE:To explore the effects of 17β-estradiol on the osteogenic differentiation of bone marrow mesenchymal stem cells(MSCs) and the underlying mechanism.METHODS:MSCs were separated,purified,cultured and expanded.Different concentrations of 17β-estradiol was administrated to MSCs for some period.The level of type I collagen in culture medium was detected by Elisa method,and the expression of Runx2 mRNA and protein was analyzed by RT-PCR or Western blotting methods,respectively.RESULTS:Compared with the control group,type I collagen expression in the MSCs was significantly increased on the 5th day after administration of 0.001,0.01,0.1 nmol/L 17β estradiol(P < 0.05) and it maintained high expression on the 7th day(P < 0.05).Runx2 mRNA expression increased in a dose-dependent manner on the 5th and 7th days after administration of 17 β-estradiol(P < 0.05).These findings suggest that 17β-estradiol can induce the osteogenic differentiation of MSCs,which occurs possibly by upregulation of Runx2 expression.
Effects of dehydroepiandrosterone on in vitro cultured osteoblasts and osteoprotegerin in rats

Jian-fen Yang,Yi-ping Sun,Wei Li,Guo-ying Zhu,Li-hua Wang

DOI: https://doi.org/10.3321/j.issn:1673-8225.2008.15.004

2008-01-01

Abstract:Background: Dehydroepiandrosterone (DHEA) derived from adrenal cortex has an indirect bioeffect through differentiating into androgen or estrogen in the related peripheral tissues. Objective: To verify the effects and mechanisms of DHEA on promoting osteoblasts (OBs) proliferation. Design, time and setting: The grouping controlled experiment was accomplished in Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University and Institute of Radiation Medicine, Fudan University from January 2006 to February 2007. Materials: Ten SD rats were recruited, 1 day old, regardless of gender. DHEA was the product of American Sigma Company. Methods: Rat OBs were separated and cultured in vitro. First generation of OBs cultured in a varied concentrations of DHEA (1 × 10-5, 1 × 10-7 and 1 × 10-9 mmol/L) for 72 hours were set up as the experiment group, while those exposed to 1 × 10-8 mmol/L of estradiol culture were regarded as positive controls and blank control group was set up as well. Main outcome measures: The OBs were identified by cell morphology and alkaline phosphatase (ALP) dyeing. Light microscope and methyl thiazolyl tetrazolium assay were used to detect the growth and proliferation of OBs. The formation of mineralized nodus was examined by alizarin bordeaux stain. The concentrations of osteoprotegerin in DHEA culture solution were also measured by double antibody sandwich ABC-ELISA simultaneously. Results: 1 Identification of primarily cultured OBs showed ALP dyeing was positive. 2 Proliferation rate of OBs was increased in experiment groups compared with that of the blank control group, and the most significant increase occurred in the concentration of 1 × 10-7 mmol/ L DHEA culture (P < 0.01). However, there was no significant difference in proliferation rate between estradiol culture and DHEA group (P > 0.05). 3 ALP activity in experiment groups was higher, especially in the group with the concentration of 1 × 10-7 nmol/L DHEA (P < 0.01). No significant differences were seen in the ALP activity between estradiol culture and DHEA groups with concentration of 1 × 10-7 and 1 × 10-9 mmol/L (P > 0.05). 4 ALP activity of unitary cell population was higher in 1 × 10-9 mmol/L DHEA culture group than that in blank control group (P < 0.05). 5 Both the area and area ratio of mineralized nodules were significantly increased in various concentrations of DHEA groups (P < 0.01), which was similar to that of estradiol culture. 6 Responds of osteoprotegerin to DHEA were the most active in 1 × 10-9 mmol/L DHEA group after 72 hours of the culture (P < 0.01), and had a positive correlation with OBs proliferation. Conclusion: DHEA may promote growth and proliferation of rat OBs, its effect at the optimal concentration of 1 × (10-7 - 10-9) mmol/L is identical with estradiol, and might be related to stimulating osteoprotegerin pathway DHEA at the concentration exceeding 1 × 10-5 mmol/L has no effect on OBs proliferation.
[The Expression of Estrogen Receptor Alpha and Beta in the Intervention of Different Estrogens in Rat Bone Metabolism].

Ning,Yi Min Zhu,He Feng Huang

DOI: https://doi.org/10.3321/j.issn:1673-520x.2006.04.001

2006-01-01

Journal of Molecular Cell Biology

Abstract:In this present study, female rats were ovariectomized (OVX) as the models of osteoporosis. The aim is to determine the different mechanisms of estrogen receptor(ER) alpha and beta pathway in mediating estrogen to participate in trabecular bone metabolism, and to further explore the distinction of modulation on ER alpha or ER beta between estrogens with different components. Mature female Sprague-Dawley rats (n=40) were randomly divided into four groups: group Control (sham operated), group OVX (only ovariectomized), group CEE (OVX rats treated with conjugated equine estrogens) and group EV (OVX rats treated with estradiol valerate). Sham operation and OVX were performed 48 days (12 estrums) before different liquid diet. The rats in group Control and group OVX were orally administrated with physiological saline solution and the rats in group CEE or group EV were orally administrated with CEE or EV for 12 days (3 estrums) before sacrifice. Relative quantitative reverse transcription- polymerase chain reaction (RT-PCR) and western blot techniques were utilized to compare the levels of ER alpha and ER beta mRNA and proteins in trabecular bone among groups. The results showed that in rat trabecular bone of group Control, the expression of ER alpha protein (1.433 +/- 0.250) was significantly higher than that of ER beta(0.687 +/- 0.120), whereas the ER alpha mRNA (0.285 +/- 0.033) was much lower than ERbeta mRNA(0.590 +/- 0.044). Following OVX, the levels of ER alpha protein (0.685 +/- 0.103) declined significantly, whereas mRNA levels (0.405 +/- 0.036) markedly increased. Both the protein (1.091 +/- 0.078) and mRNA (0.729 +/- 0.030) levels of ER beta significantly increased after OVX. After treatment with CEE, the expression of ER beta protein (0.583 +/- 0.129) and mRNA (0.618 +/- 0.043) were markedly down-regulated compared with group OVX. After treatment with EV, the ER alpha protein expression (1.272 +/- 0.247) was markedly up-regulated, while ERa mRNA (0.277 +/- 0.040) and ER beta protein (0.620 +/- 0.174) were markedly down-regulated compared with group OVX. On the other hand, the loss of bone mass in rat trabecular bone by OVX (0.192 +/- 0.010) was markedly gained after CEE (0.228 +/- 0.012) and EV (0.259 +/- 0.007) treatment. These results demonstrate that ERalpha may be the predominant subtype expressed in female rat trebecular bone and play a key role in the bone metabolism. This study also shows that estrogens with different components protect bone through variant ERs pathway.

Potential utilization of Artemiafranciscana eggs as food for Coleomegillamaculata

Aspects of energetic substrate metabolism of in vitro and in vivo bovine embryos

Effect of 17Β-Estradiol on the Migration Ability of Human Osteosarcoma U2OS Cells

Food-based nutrition education and hygiene can improve the growth of stunted children.

The Impact of Stapes Surgery on Osteogenesis Imperfecta: a Retrospective Comparison of Operative Outcomes with Those for Patients with Otosclerosis

SUN-LB003 the Steroid Sulfatase Dictates the Hormone Replacement Therapy Efficacy of the Conjugated Equine Estrogen

The Disease-Modifying Effect of Dehydroepiandrosterone in Different Stages of Experimentally Induced Osteoarthritis: a Histomorphometric Study

Effect of 17-β estradiol on the expression of receptor activator of nuclear factor κB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation

Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions

Effects of 17Β-Estradiol on Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and Adipocytic Trans-Differentiation of Osteoblasts

Interactive use of a computer in the preparation of structured programs

Effect of 17β-estradiol on the gene expression of estrogen receptors and estrogen related-receptor α in the periosteum-derived osteogenic cells

[7. Let's write a research paper soon after returning; introduction of the international journals related to radiological technology and members' real experiences].

Estrogen's Stimulating Effect on ATDC5

Effect of stapes demineralisation on the development of cochlear otosclerosis

Estrogens and Hyperglycemic Modulation of mRNAs Expressions Involved in Bone Metabolism: An Overshadowed Association?

Altered extracellular matrix and mechanotransduction gene expression in rat bone tissue following long-term estrogen deficiency

Effects of estrogen treatment on the proliferation and differentiation of bone marrow stromal cells from normal rats and osteoporosis rats

Effects of 17 beta-estradiol on osteogenic differentiation of rat primary cultured bone marrow mesenchymal stem cells

Effects of dehydroepiandrosterone on in vitro cultured osteoblasts and osteoprotegerin in rats

[The Expression of Estrogen Receptor Alpha and Beta in the Intervention of Different Estrogens in Rat Bone Metabolism].